Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/10646
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMikhailidis, D. P.en
dc.contributor.authorElisaf, M.en
dc.contributor.authorRizzo, M.en
dc.contributor.authorBerneis, K.en
dc.contributor.authorGriffin, B.en
dc.contributor.authorZambon, A.en
dc.contributor.authorAthyros, V. G.en
dc.contributor.authorde Graaf, J.en
dc.contributor.authorMarz, W.en
dc.contributor.authorParhofer, K. G.en
dc.contributor.authorRini, G. B.en
dc.contributor.authorSpinas, G. A.en
dc.contributor.authorTomkin, G. H.en
dc.contributor.authorTselepis, A. D.en
dc.contributor.authorWierzbicki, A. S.en
dc.contributor.authorWinkler, K.en
dc.contributor.authorFlorentin, M.en
dc.contributor.authorLiberopoulos, E.en
dc.date.accessioned2015-11-24T16:58:01Z-
dc.date.available2015-11-24T16:58:01Z-
dc.identifier.issn1570-1611-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/10646-
dc.rightsDefault Licence-
dc.subjectldlen
dc.subjectsubclassesen
dc.subjectatherosclerosisen
dc.subjectcardiovascular risken
dc.subjectstatementen
dc.subjectcoronary-artery-diseaseen
dc.subjectcholesteryl ester transferen
dc.subjectfamilial combined hyperlipidemiaen
dc.subjecttype-2 diabetes-mellitusen
dc.subjectnuclear-magnetic-resonanceen
dc.subjectvery-low-densityen
dc.subjectapolipoprotein-b metabolismen
dc.subjectintima-media thicknessen
dc.subjectischemic-heart-diseaseen
dc.subjectc-reactive proteinen
dc.titleEuropean Panel on Low Density Lipoprotein (LDL) Subclasses: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclassesen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondary<Go to ISI>://000295413500002-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2011-
heal.abstractAim of the present Consensus Statement is to provide a comprehensive and up to-date document on the pathophysiology, atherogenicity and clinical significance of low density lipoproteins (LDL) subclasses. We sub-divided our Statement in 2 sections: section I discusses the pathophysiology, atherogenicity and measurement issues, while section II is focused on the effects of drugs and lifestlyle modifications. Suggestions for future research in the field are highlighted at the end of section II. Each section includes Conclusions.en
heal.journalNameCurr Vasc Pharmacolen
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons